Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Enforcing A Belated Chemistry Lesson – The Nitrosamines In Sartans Saga

Aug 22 2019

• By Bowman Cox

Lantech — Solvent recovery operations are a major point of concern • Source: Lantech Pharmaceuticals

Related Content

Aurobindo Faulted In US FDA Warning Letter For Poor Root Cause Investigations

Jul 03 2019

As Recalls Multiply, EU Agency Studies How To Rid Chinese Firm’s Valsartan API Of Probable Carcinogen

Jul 20 2018

US FDA Warning Letter Draws Indian Solvent Recycler Into Valsartan Crisis

Aug 16 2019

Related Companies

Aurobindo Pharma Limited

Zhejiang Huahai Pharmaceutical Co., Ltd.

Hetero Drugs Ltd.

Additional Topics

Europe United States India Asia Pacific China Manufacturing Quality Enforcement Compliance BioPharmaceutical

More from Manufacturing

More from Compliance

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.